会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 21. 发明公开
    • Ethanolamine derivatives
    • EP0220054A3
    • 1987-12-02
    • EP86307974
    • 1986-10-15
    • GLAXO GROUP LIMITED
    • Finch, HarryLunts, Lawrence Henry CharlesNaylor, AlanSkidmore, Ian FrederickCampbell, Ian BaxterMiddlemiss, DavidWillbe, Charles
    • C07D213/38C07C143/75C07C93/00C07C93/08C07C127/17C07C93/14C07C125/065C07C103/76C07C103/38C07D295/08A61K31/135
    • C07D295/096C07D213/65Y10S514/826
    • The present invention provides compounds of the general formula (I)
      wherein
      Ar represents a phenyl group optionally substituted by one or more substituents selected from halogen atoms, or the groups C 1-6 alkyl, nitro, -(CH 2 )qR, [where R is hydroxy, C 1-6 alkoxy, -NR3R4 (where R3 and R 4 each represents a hydrogen atom, or a C 1-4 alkyl group, or -NR 3 R 4 forms a saturated heterocyclic amino group which has 5-7 ring members and optionally contains in the ring one or more atoms selected from -O- or -S-or a group -NH- or -N(CH 3 )-), -NR 5 COR 6 (where R 5 represents a hydrogen atom or a C 1-4 alkyl group, and R 6 represents a hydrogen atom or a C 1-4 alkyl, Ci- 4 alkoxy, phenyl or -NR 3 R 4 group), -NR S S0 2 R 7 (where R 7 represents a C 1-4 alkyl, phenyl or -NR3R4 group), -COR 8 (where R 8 represents hydroxy, C 1-4 alkoxy or-NR 3 R 4 ), -SR 9 (where R 9 is a hydrogen atom, or a C 1-4 alkyl or phenyl group), -SOR 9 , -S0 2 R 9 , or -CN, and q represents an integer from 0 to 3], or -O(CH 2 ) 1 R 10 [where R 10 represents a hydroxy or C 1-4 alkoxy group, and t is an integer 2 or 3], or Ar is a phenyl group substituted by an alkylenedioxy group of formula -O(CH 2 )pO-, where p represents an integer 1 or 2: R 1 and R 2 each represents a hydrogen atom or a C 1-3 alkyl group with the proviso that the sum total of carbon atoms in R 1 and R 2 is not more than 4; X represents a bond or a C 1-7 alkylene, C 2 - 7 alkynylene or C 2 - 7 alkenylene chain and Y represents a bond or a C 1-6 alkylene, C 2-6 alkenylene or C 2-6 alkynylene chain with the proviso that the sum total of carbon atoms in X and Y is 2-10; Q represents the group
      [where Q 1 represents C 1-3 alkoxy, methanesulphonyl or cyano) or the group -CH 2 NHR 11 (where R 11 represents R 12 CO-. R 12 NHCO-. R 12 R 13 NSO 2 - or R 14 SO 2 -, where R 12 and R 13 each represent a hydrogen atom or a C 1-3 alkyl group, and R 14 represents a C 1-3 alkyl group), or the group -NR 15 R 16 (where R 15 represents a hydrogen atom or a C 1-4 alkyl group, and R 16 represents a hydrogen atom or a C 1-4 alkyl group or, when R 15 is a hydrogen atom. R 16 also represents a C 1-4 alkoxycarbonyl group)]. or Q represents the group
      or Q represents a phenyl group substituted by a hydroxy group and optionally also by a halogen atom; and physiologically acceptable salts and solvates (e.g. hydrates)thereof. The compounds have a stimulant action at β2-adrenorecep- tors and may be used in the treatment of diseases associated with reversible airways obstruction such as asthma and chronic bronchitis.
    • 22. 发明公开
    • Ethanolamine compounds
    • Ethanolaminverbindungen。
    • EP0220878A2
    • 1987-05-06
    • EP86307975.2
    • 1986-10-15
    • GLAXO GROUP LIMITED
    • Finch, HarryNaylor, AlanLunts, Lawrence Henry CharlesSkidmore, Ian Frederick
    • C07C93/08C07C93/10C07C93/14A61K31/135C07D213/18C07D295/08C07C103/76C07C103/38C07C125/065C07C127/17C07C143/75
    • C07D213/65
    • he invention provides compounds of the general formula
      wherein

      Ar represents a phenyl group optionally substituted by one or more substituents selected from halogen atoms, or the groups C 1-6 alkyl, nitro. -(CH 2 ) q R, [where R is hydroxy, C 1-6 alkoxy, -NR 3 R 4 (where R 3 and R 4 each represents a hydrogen atom, or a C 1-4 alkyl group, or -NR 3 R 4 forms a saturated heterocyclic amino group which has 5-7 ring members and optionally contains in the ring one or more atoms selected from -O- or -S-or a group -NH- or -N(CH 3 )-), -NR 5 COR 6 (where R 6 represents a hydrogen atom or a C 1-4 alkyl group, and R 6 represents a hydrogen atom or a C 1-4 alkyl, C 1-4 alkoxy, phenyl or -NR 3 R 4 group). -NR 5 S0 2 R 7 (where R 7 represents a C 1-4 alkyl, phenyl or -NR 3 R 4 group), -COR 8 (where R 8 represents hydroxy, C 1-4 alkoxy or -NR 3 R 4 ), -SR 9 (where R 9 is a hydrogen atom, or a C 1-4 alkyl or phenyl group). -SOR 9 , -S0 2 R 9 , or -CN, and q represents an integer from 0 to 3], or -O(CH 21 R 11 [where R" represents a hydroxy or C 1-4 alkoxy group and t is 2 or 3], or Ar is a phenyl group substituted by an alkylenedioxy group of formula -O(CH 2 )pO-, where p represents 1 or 2;
      R' and R 2 each represent a hydrogen atom or a C 1-3 alkyl group, with the proviso that the sum total of carbon atoms in R 1 and R 2 is not more than 4;
      R 20 represents a C 1-3 alkyl group;
      X represents a C 2-8 alkylene C 2-8 alkenylene or C 2-8 alkynylene chain, and
      Y represents a C 1-7 alkylene C 2-7 alkenylene or C 2-7 alkynylene chain. with the proviso that the sum total of carbon atoms in X
      and Y is 4 to 12; Q represents (a)
      EMI PA=2 FR= 1 HE=30 WI=40 TI=CHE (where R' 2 is a straight or branched C 1-3 alkylene group).
      (where one of R 13 and R 14 is a hydroxy group and the other is a hydrogen or halogen atom or a hydroxy group),
      [where R 15 is a group R 16 CO-, R 16 NHCO-, R 16 R 17 NSO 2 - or R 18 SO 2 - (where R' 6 and R 17 is each a hydrogen atom or a C 1-3 alkyl group and R 18 is a C 1-3 alkyl group) and p is an integer 0 or 1],
      (where R 26 and R 27 is each a hydrogen atom or a C 1-3 alkyl group or. when R 26 is a hydrogen atom, R 27 may also be a C 1-4 alkoxycarbonyl group),
      (where R 19 is a C 1-3 alkyl group),


      or (i)
      and physiologically acceptable salts and solvates (e.g. hydrates) thereof.

      The compounds have a stimulant action at β 2 -adrenorecep- tors and may be used in the treatment of diseases associated with reversible airways obstruction such as asthma and chronic bronchitis.
    • 本发明提供了通式(I)的化合物,其中Ar表示任选被一个或多个选自卤原子的取代基取代的苯基,或基团C 1-6烷基,硝基, - (CH 2)q R [其中 R是羟基,C 1-6烷氧基,-NR 3 R 4(其中R 3和R 4各自表示氢原子或C 1-4烷基或-NR 3 R 形成饱和杂环氨基,其具有5-7个环成员并且任选在环中含有一个或多个选自-O-或-S-或-NH-或-N(CH 3) - 基团的原子), -NR 5 COR 6(其中R 6表示氢原子或C 1-4烷基,R 6表示氢原子或C 1-4烷基,C 1-4烷氧基,苯基或 -NR 3 R 4基团),-NR 5 SO 2 R 7(其中R 7表示C 1-4烷基,苯基或-NR 3 R 4基团),-COR <8>(其中R 8表示羟基,C 1-4烷氧基或-NR 3 R 4),-SR 9(其中R 9为氢原子或C 1-4烷基 或苯基),-SOR 9,-SO 2 R 9或-CN,q表示0〜3的整数] 或-O(CH 2 t R 1)其中R 1表示羟基或C 1-4烷氧基,t为2或3],或Ar为被亚烷基二氧基取代的苯基 式-O(CH 2)p O-,其中p表示1或2; R 1和R 2各自表示氢原子或C 1-3烷基,条件是R 1和R 2中的碳原子总和不大于4; R 2表示C 1-3烷基; X表示C2-8亚烷基C2-8亚烯基或C2-8亚炔基链,Y表示C1-7亚烷基C2-7亚烯基或C2-7亚炔基链,条件是X和 Y为4〜12; Q表示(a)(其中R 1> 2是直链或支链C 1-3亚烷基),(其中R 1> 3和R 1> 4 >是羟基,另一个是氢或卤素原子或羟基), [其中R 1'5是基团R 1 -C 6 - ,R 1' NCO 2 - 或R 1 SO 2 - (其中R 1〜6和R 1〜7)分别为 氢原子或C 1-3烷基,R 1是C 1-3烷基),p是整数0或1],(其中R 2&lt; 6&gt;和R R 2为氢原子或C 1-3烷基,或者当R 2为6时,R 2为氢原子时,R 2也可为C 1-4烷氧基羰基) ,(其中R 1 <9>为C 1-3烷基),及其生理上可接受的盐和溶剂合物(例如水合物)。 这些化合物在β2肾上腺素受体具有刺激作用,可用于治疗与可逆气道阻塞如哮喘和慢性支气管炎相关的疾病。